| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/02/2013 | CA2445729C Use of metals to treat mucosal membranes |
| 07/02/2013 | CA2379012C In vitro reconstitution of segmented negative-strand rna viruses |
| 07/02/2013 | CA2251009C Medicament for optimising mucosal viscosity and stimulating intestinal function |
| 06/27/2013 | WO2013096785A1 2-substituted-thienoquinolones and related compounds as anti-infective agents |
| 06/27/2013 | WO2013096744A1 Hepatitis b antiviral agents |
| 06/27/2013 | WO2013096681A1 Pyrazolo[1,5-a]pyrimidines as antiviral agents |
| 06/27/2013 | WO2013096680A1 Substituted phosphorothioate nucleotide analogs |
| 06/27/2013 | WO2013096679A1 Substituted nucleosides, nucleotides and analogs thereof |
| 06/27/2013 | WO2013096577A1 Antimicrobial composition for animal welfare |
| 06/27/2013 | WO2013096512A1 Pharmaceutical compositions and methods for treating gastrointestinal infections and disorders |
| 06/27/2013 | WO2013096182A2 Compositions comprising gallates and gallamides |
| 06/27/2013 | WO2013095275A1 Novel hepatitis c virus inhibitors |
| 06/27/2013 | WO2013095169A1 Crystalline minocycline thermo-resistant obtained by recrystallization with carbon dioxide |
| 06/27/2013 | WO2013095166A1 Antibiotic formulations |
| 06/27/2013 | WO2013095091A2 Rsv g protein specific antibodies |
| 06/27/2013 | WO2013094574A1 Mixed valence copper compound-loaded tungsten oxide and method for producing same |
| 06/27/2013 | WO2013094573A1 Copper-and-titanium-containing composition and production method therefor |
| 06/27/2013 | WO2013094572A1 Copper-and-titanium-containing composition and production method therefor |
| 06/27/2013 | WO2013093940A1 Nitrofurfuryl substituted phenyl linked piperidino-oxadiazoline conjugates as anti-tubercular agents and process for the preparation thereof |
| 06/27/2013 | WO2013093790A1 A composition for reducing an hiv viral load comprising praziquantel, niclosamide and albendazole |
| 06/27/2013 | WO2013093615A1 Tricyclic boron compounds for antimicrobial therapy |
| 06/27/2013 | WO2013092509A1 Inhibitors of sialoadhesin for the treatment of diseases caused by enveloped viruses |
| 06/27/2013 | WO2013092481A1 2',4'-difluoro-2'-methyl substituted nucleoside derivatives as inhibitors of hcv rna replication |
| 06/27/2013 | WO2013092447A1 4'-azido, 3'-fluoro substituted nucleoside derivatives as inhibitors of hcv rna replication |
| 06/27/2013 | WO2013091539A1 Pyrrole six-membered heteroaryl ring derivative, preparation method therefor, and medicinal uses thereof |
| 06/27/2013 | WO2013091282A1 Cajanine structure analogous compound, preparation method and use |
| 06/27/2013 | WO2013091260A1 Carious tooth vaccine and preparation method |
| 06/27/2013 | WO2013091164A1 Small molecule polypeptide for preventing and restraining inflammation and application of same |
| 06/27/2013 | WO2013091144A1 Propenoate derivatives of betulin |
| 06/27/2013 | WO2013091096A1 Condensed triclyclic compounds as inhibitors of hiv replication |
| 06/27/2013 | WO2013091089A1 Three-dimensional cavities of dendritic cell immunoreceptor (dcir), compounds binding thereto and therapeutic applications related to inhibition of human immunodeficiency virus type-1 (hiv-1) |
| 06/27/2013 | WO2013091080A1 Vesicular stomatitis virus for prime boost vaccines |
| 06/27/2013 | WO2013091056A1 Pharmaceutical compositions comprising arrabidaea chica extract in controlled release systems, production process and use thereof |
| 06/27/2013 | WO2013091053A1 Polymer composition containing natural bioactive principles for use in pharmaceutical and cosmetic formulations |
| 06/27/2013 | WO2013091014A1 Antimicrobial agents |
| 06/27/2013 | WO2013091011A1 Heterocyclic urea compounds |
| 06/27/2013 | WO2013091004A1 Prevention and treatment of mycobacterium infection |
| 06/27/2013 | WO2013063462A3 Method of treating hcv infection with a small molecule chk2 inhibitor |
| 06/27/2013 | WO2013040564A3 Antibody recognizing arbitrarily designed epitope of three or more amino acid residues in a peptide and method of generating thereof |
| 06/27/2013 | US20130165419 Combination anti-inflammatory ophthalmic compositions |
| 06/27/2013 | US20130164843 Method and medicament for inhibiting the expression of a given gene |
| 06/27/2013 | US20130164823 Expression System |
| 06/27/2013 | US20130164733 Hepatitis-c virus testing |
| 06/27/2013 | US20130164366 Method and medicament for inhibiting the expression of a given gene |
| 06/27/2013 | US20130164315 Vaccines - Screening Method |
| 06/27/2013 | US20130164298 P. gingivalis antigenic composition |
| 06/27/2013 | US20130164259 1,4-substituted piperazine derivatives and methods of use thereof |
| 06/27/2013 | US20130164258 Antiviral Compounds Composed of Three Aligned Aryl Moieties to Treat Diseases such as Hepatitis C |
| 06/27/2013 | US20130164255 Immunotherapy for reversing immune suppression |
| 06/27/2013 | US20130164250 Method for production of bioresorbable microparticles, microparticles thus obtained and use thereof |
| 06/27/2013 | US20130164228 Compositions comprising gallates and gallamides |
| 06/27/2013 | CA2858963A1 Vaccines against hpv |
| 06/27/2013 | CA2858096A1 Pyrazolo[1,5-a]pyrimidines as antiviral agents |
| 06/27/2013 | CA2858090A1 Pharmaceutical compositions and methods for treating gastrointestinal infections and disorders |
| 06/27/2013 | CA2857977A1 Pyrrole six-membered heteroaryl ring derivative, preparation method thereof, and medicinal uses thereof |
| 06/27/2013 | CA2857344A1 Hepatitis b antiviral agents |
| 06/27/2013 | CA2856179A1 2',4'-difluoro-2'-methyl substituted nucleoside derivatives as inhibitors of hcv rna replication |
| 06/27/2013 | CA2855894A1 Pseudomonas aeruginosa oprm epitopes for use in diagnostics and therapeutics |
| 06/26/2013 | EP2607370A2 Amorphous form of beta- L-2'-deoxythymidine |
| 06/26/2013 | EP2607361A1 Thiirane and michael acceptor compounds and their medical use |
| 06/26/2013 | EP2606898A1 Composition comprising ligustroflavone, rhoifolin and hyperin, and use thereof in the preparation of a medicament |
| 06/26/2013 | EP2606897A1 Methods and compositions for the treatment of diseases caused by enveloped viruses |
| 06/26/2013 | EP2606895A1 Transdermal absorption patch of antiviral drug and its preparation method |
| 06/26/2013 | EP2606885A1 Medicinal preparation "renessans" having an antibacterial, anti-ulcerous and immuno-modulating action |
| 06/26/2013 | EP2606047A1 Lipidated immune response modifier compound compositions, formulations, and methods |
| 06/26/2013 | EP2606041A2 Compounds and methods for the treatment or prevention of flaviviridae viral infections |
| 06/26/2013 | EP2606038A1 Compounds for the treatment of hepatitis c |
| 06/26/2013 | EP2605831A1 Method for producing non-alcoholic plant-based compositions, compositions produced in said manner and use thereof |
| 06/26/2013 | EP2605797A2 Therapeutic peptide-polymer conjugates, particles, compositions, and related methods |
| 06/26/2013 | EP2605789A2 Modified relaxin polypeptides and their uses |
| 06/26/2013 | EP2605785A1 Method for producing non-alcoholic compositions, compositions produced in said manner and use thereof |
| 06/26/2013 | EP2605770A1 Antifungal agents and uses thereof |
| 06/26/2013 | CN103180342A Antibodies for the treatment of HIV |
| 06/26/2013 | CN103180341A Monoclonal antibody specific to major neutralizing epitope of influenza h5 hemagglutinin |
| 06/26/2013 | CN103180333A Glycodendrimers of polypropyletherimine |
| 06/26/2013 | CN103180328A Cyclic boronic acid ester derivatives and therapeutic uses thereof |
| 06/26/2013 | CN103180310A Hetero-bicyclic derivatives as hcv inhibitors |
| 06/26/2013 | CN103180295A 多环四环素化合物 Polycyclic tetracycline compounds |
| 06/26/2013 | CN103179987A Pharmaceutical composition and method of inhibiting of production or amplifying elimination of p24 protein |
| 06/26/2013 | CN103179974A New treatments of hepatitis c virus infection |
| 06/26/2013 | CN103179966A Vitamin e formulations of sulfamide ns3 inhibitors |
| 06/26/2013 | CN103179961A Antifungal agents and uses thereof |
| 06/26/2013 | CN103173470A Preparation of PCV2 ORF2 capsid protein virus-like particles derived from escherichia coli |
| 06/26/2013 | CN103173455A Goose-origin gene RIG-I (retinoic acid-inducible gene-I) with anti-Newcastle disease virus activities and application thereof |
| 06/26/2013 | CN103173452A Aptamer capable of simultaneously identifying OdDHL ([N-(3-oxododecanoyl)-L-homoserine lactone]) and BHL (N-butanoyl-L-homoserine lactone) and application thereof |
| 06/26/2013 | CN103173373A High-antibacterial-activity Pediococcus acidilactici strain and application thereof |
| 06/26/2013 | CN103173372A High-antibacterial-activity Lactococcus lactis strain and application thereof |
| 06/26/2013 | CN103173357A Ceriporia lacerata and application thereof |
| 06/26/2013 | CN103173337A Acanthopanax tartary buckwheat wine and brewing method thereof |
| 06/26/2013 | CN103172760A Method for preparing sulfated glycogen based on oysters or scallops |
| 06/26/2013 | CN103172751A Fusion protein of PA4-Fc and coding gene and application thereof |
| 06/26/2013 | CN103172749A Preparation of African swine fever protein engineering vaccine |
| 06/26/2013 | CN103172734A Humanized anti-anthrax-toxin protective antigen neutralizing antibody Fab and applications thereof |
| 06/26/2013 | CN103172723A Rana margaratae antimicrobial peptide odorranain-H-OM1 as well as gene of coded sequence and application thereof |
| 06/26/2013 | CN103172721A Amolops hainanensis antimicrobial peptide Hainanenin-1, and gene, separation purification, chemical synthesis and application thereof |
| 06/26/2013 | CN103172710A Modified influenza virus for monitoring and improving vaccine efficiency |
| 06/26/2013 | CN103172709A IBDV (Infectious Bursal Disease Virus) VP2 protein and IBD subunit vaccine |
| 06/26/2013 | CN103172705A Hepatitis C virus (HCV) B cell epitope peptide PUHI16 and application thereof |
| 06/26/2013 | CN103172703A Tuberculosis-resisting-drug-related efflux-protein-sourced tuberculosis resisting CTL (Cytotoxic T Lymphocyte) epitope peptide and application thereof |
| 06/26/2013 | CN103172702A Tuberculosis-resisting-drug-related efflux-protein-sourced tuberculosis resisting CTL (Cytotoxic T Lymphocyte) epitope peptide and application thereof |